期刊文献+

桑皮素对Ⅱ型糖尿病模型鼠降血糖作用的研究 被引量:3

Experimental study of mulberrin on blood glucose of Type Ⅱ diabetes model rats
下载PDF
导出
摘要 目的探讨桑皮素对Ⅱ型糖尿病模型鼠血糖、胰岛素、糖化血红蛋白和糖耐量的影响。方法根据中药新药研究指南(降糖药)药效学实验要求,选择正常小鼠(KM小鼠),自发性糖尿病小鼠(NOD小鼠)及链脲霉素加高热饲料导致的Ⅱ型糖尿病大鼠,灌胃给予不同剂量的桑皮素,研究其对血糖、胰岛素、糖化血红蛋白的影响。结果 (1)桑皮素50.0、25.0、12.5 mg/kg连续灌胃给药14 d后,对正常小鼠血糖无明显影响,差异无统计学意义(P>0.05);对NOD小鼠血糖有明显的降低作用,差异有统计学意义(P<0.05)。(2)桑皮素30.0、15.0、7.5 mg/kg连续灌胃给药14 d,对链脲霉素加高热饲料导致的Ⅱ型糖尿病大鼠有明显作用,改善糖尿病动物的糖耐量,差异有统计学意义(P<0.05);15.0、30 mg/kg组动物血糖浓度、胰岛素和糖化血红蛋白均降低,与模型组比较差异有统计学意义(P<0.05)。结论桑皮素对Ⅱ型糖尿病模型大鼠血糖有明显的降低作用。 Objective The experiment had investigated the results by using mulberrin on blood glucose,insulin,glycated hemoglobin, glucose tolerance of Type II diabetes model rats. Method According to Chinese herbal medicine research guide (oral) pharmacodynamics experi- nlent demands, choose the normal mice (KM mice), spontaneous diabetic mice (NOD mice) and chain fosomycin heightening urea to heat feed type II diabetes rats, fill the stomach give different doses of mulberry element, research on the blood glucose, insulin, glycated hemoglobin influence. Results 1. The concentration of blood glucose of regular lab rats has no visibly changed (P〉0.05)after using mulberrin of 50.0, 25.0, 12.5 mg/kg by oral administration for 14 days. By contrast, the blood glucose were obviously lower and rates of Insulin were ob- viously higher(P〈0.05) in NOD rats. 2. The concentration of blood glucose of has reduced obviously after using rnulberrin of 30.0, 15.0, 7.5 mg/kg). Compare with the regular group, the rates of Insulin and Glycosylated Hemoglobin were obviously lower(P〈0.05) after using mulberrin of 30,15 mg/kg by oral administration for 14 days. Conclusion Mulberrin has significantly reduced role on blood sugar of type II diabetes model of rats.
出处 《湖南中医药大学学报》 CAS 2011年第5期26-28,33,共4页 Journal of Hunan University of Chinese Medicine
基金 湖南省科技厅科研条件创新项目[0C2513]
关键词 桑皮素 Ⅱ型糖尿病 大鼠 血糖 胰岛素 糖化血红蛋白 mulberrin Type II diabetes hamster blood glucose insulin Glycated hemoglobin
  • 相关文献

参考文献4

二级参考文献13

  • 1[1]Sima A, Garcia- Salinas R, Basu P. The BB Wistar rat: an experimental model for the study of diabetic retinopathy.Metabolism, 1983, 32 (Suppl 1): 136~138.
  • 2[2]Gardiner TA, Stitt AW, Anderson HR, et al. Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs. Br J Ophthalmol, 1994, 78: 54~57.
  • 3[3]Junod A, Lamber AE Orci L, et al. Studies of the diabetogenic action of streptozotocin. PTOC Soc Exp Biol Med, 1967, 125:201 ~ 203.
  • 4[4]Rackietan N, Rackietan ML, Nadkarni MR. Rtudies on diabetogenic action of streptozotocin (NSC- 37917) Cancer ChemotherapyReports, 1993, 29: 91~95.
  • 5[5]John PM. Animal models of diabetes. Am J Med, 1981, 70:353~355.
  • 6[6]Ssaki k. Studies on diabetic cataract in rats induced by streptozotocin. Ophthalmic Res, 1983, 15: 185~187.
  • 7[7]Arison RN, Ciaccio EI, Glitzer MS, et al. Light and electron microscopy of lesions in rats rendered diabetic with streptozotocin.Diabetes,1967,16:51~54.
  • 8[8]Ledoux SP, Wilson GL. Effects of streptozotocin on a donal isolate of rat insulinoma cells. Biochem biophys Acte, 1984, 804:387~ 389.
  • 9[9]Pettepher CC, Ledoux SP, Bohr VA, et al. Repair pf alkalilabile sites within the mitochondrial DNA of RINr 38 cells after exposure to the nitrosourea streptozotocin J. Biochem, 1991, 266:3113~3116.
  • 10谢明智,刘海帆,张凌云,申竹芳,陈其明.实验性肥胖及糖尿病大鼠模型[J]药学学报,1985(11).

共引文献79

同被引文献98

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部